LACTATE TRANSPORT IS MEDIATED BY A MEMBRANE-BOUND CARRIER IN RAT SKELETAL-MUSCLE SARCOLEMMAL VESICLES

被引:166
作者
ROTH, DA [1 ]
BROOKS, GA [1 ]
机构
[1] UNIV CALIF BERKELEY,DEPT PHYS EDUC,EXERCISE PHYSIOL LAB,BERKELEY,CA 94720
关键词
D O I
10.1016/0003-9861(90)90505-S
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To study the kinetics of lactate transport in an isolated, nonmetabolizing system, skeletal muscle sarcolemmal membrane vesicles were purified from 22 female Sprague-Dawley rats. l(+)-[U-14C] Lactate at 10 concentrations demonstrated saturation kinetics with a Vmax of 139.4 nmol/mg/min, and an apparent Km of 40.1 mm. Threefold higher initial rates of l(+)-lactate uptake were seen at 37 °C than at 25 °C, indicating temperature sensitivity. Transport was stereospecific for the l(+) isomer: isotopic d(-) uptake rates remained linear at concentrations from 1 to 200 mm, and 1 mm d(-) remained 6-fold lower in net uptake after 60 min than the l(+) isomer. Furthermore, unlabeled 10 mm d(-)-lactate in the external medium could only inhibit 1 mm isotopic (l(+) uptake by 12%, whereas unlabeled 10 mm l(+)-lactate and pyruvate inhibited 82 and 71%, respectively. Additionally, 10 mm β-hydroxybutyrate and acetoacetate could moderately inhibit (27 and 32%, respectively) 1 mm l(+)-lactate transport, but the unsubstituted aliphatic monocarboxylates (formate, acetate, propionate), tricarboxylic acid cycle intermediates (malate, succinate, oxaloacetate, α-ketoglutyrate, citrate), amino acids (alanine, aspartate, glutamate), and palmitate or adenosine in 10-fold excess could not effectively inhibit 1 mm l(+)lactate uptake under cistransport conditions. 4,4′-Diisothiocyanostilbene-2,2′-disulfonic acid could inhibit l(+)-lactate transport by only 13%, so that lactate transport does not appear to be affected directly by Cl- or HCO3- fluxes. It was demonstrated that KCl could not evoke a membrane potential-induced overshoot of lactate uptake in the presence or absence of valinomycin. Moreover, gluconate could substitute for Cl-, indicating that Cl- flux does not contribute to a membrane potential-dependent component of the transport mechanism, suggesting an electroneutral translocation process. Protein-modifying reagents significantly inhibited 1 mml(+)-lactate transport during pH-stimulated conditions (p-chloromercuriphenyl-sulfonic acid, 83%; N-ethylmaleimide, 86%; HgCl2, 56%; mersalyl, 63% inhibition). We conclude that the skeletal muscle lactate transporter is a membranebound protein, specifically associated with the sarcolemma, that demonstrates saturation kinetics, competition, stereospecificity, and sensitivity to temperature as well as various ionic cis-inhibitors. The lactate transporter is a potentially important regulator of lactate flux across skeletal muscle, and may help to regulate intracellular pH and intermediary metabolism during lactic acidosis. © 1990.
引用
收藏
页码:377 / 385
页数:9
相关论文
共 28 条
  • [1] ASYMMETRY IN THE TRANSPORT OF LACTATE BY BASOLATERAL AND BRUSH-BORDER MEMBRANES OF RAT-KIDNEY CORTEX
    BARACNIETO, M
    MURER, H
    KINNE, R
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1982, 392 (04): : 366 - 371
  • [2] ISOLATION AND CHARACTERIZATION OF CARDIAC SARCOLEMMA
    BERS, DM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 555 (01) : 131 - 146
  • [3] SODIUM-CALCIUM EXCHANGE AND SIDEDNESS OF ISOLATED CARDIAC SARCOLEMMAL VESICLES
    BERS, DM
    PHILIPSON, KD
    NISHIMOTO, AY
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 601 (02) : 358 - 371
  • [4] BESCH HR, 1976, CIRC RES, V39, P586, DOI 10.1161/01.RES.39.4.586
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] Brooks G.A., 1985, CIRCULATION RESP MET, P208
  • [7] BROOKS GA, 1986, FASEB J, V45, P2924
  • [8] BROOKS GA, 1987, ADV MYOCHEMISTRY, P319
  • [9] EFFECT OF CHANGES IN LACTATE UPTAKE ON INTRACELLULAR PH OF PERFUSED RAT LIVER
    COHEN, RD
    ILES, RA
    BARNETT, D
    HOWELL, MEO
    STRUNIN, J
    [J]. CLINICAL SCIENCE, 1971, 41 (02) : 159 - &
  • [10] LACTIC-ACIDOSIS REVISITED
    COHEN, RD
    WOODS, HF
    [J]. DIABETES, 1983, 32 (02) : 181 - 191